[1]
Monsalve-Naharro JÁ, Domingo-Chiva E, García Castillo S, Cuesta-Montero P, Jiménez-Vizuete JM. Inhaled nitric oxide in adult patients with acute respiratory distress syndrome. Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria. 2017 Mar 1:41(2):292-312. doi: 10.7399/fh.2017.41.2.10533. Epub 2017 Mar 1
[PubMed PMID: 28236803]
[2]
Steinhorn RH. Therapeutic approaches using nitric oxide in infants and children. Free radical biology & medicine. 2011 Sep 1:51(5):1027-34. doi: 10.1016/j.freeradbiomed.2011.01.006. Epub 2011 Jan 13
[PubMed PMID: 21237265]
[3]
Hunt JL, Bronicki RA, Anas N. Role of Inhaled Nitric Oxide in the Management of Severe Acute Respiratory Distress Syndrome. Frontiers in pediatrics. 2016:4():74. doi: 10.3389/fped.2016.00074. Epub 2016 Aug 2
[PubMed PMID: 27532031]
[4]
Matthay MA, Zemans RL, Zimmerman GA, Arabi YM, Beitler JR, Mercat A, Herridge M, Randolph AG, Calfee CS. Acute respiratory distress syndrome. Nature reviews. Disease primers. 2019 Mar 14:5(1):18. doi: 10.1038/s41572-019-0069-0. Epub 2019 Mar 14
[PubMed PMID: 30872586]
[5]
Goldbart A, Golan-Tripto I, Pillar G, Livnat-Levanon G, Efrati O, Spiegel R, Lubetzky R, Lavie M, Carmon L, Ghaffari A, Nahum A. Inhaled nitric oxide therapy in acute bronchiolitis: A multicenter randomized clinical trial. Scientific reports. 2020 Jun 15:10(1):9605. doi: 10.1038/s41598-020-66433-8. Epub 2020 Jun 15
[PubMed PMID: 32541773]
Level 1 (high-level) evidence
[6]
Bagate F, Tuffet S, Masi P, Perier F, Razazi K, de Prost N, Carteaux G, Payen D, Mekontso Dessap A. Rescue therapy with inhaled nitric oxide and almitrine in COVID-19 patients with severe acute respiratory distress syndrome. Annals of intensive care. 2020 Nov 4:10(1):151. doi: 10.1186/s13613-020-00769-2. Epub 2020 Nov 4
[PubMed PMID: 33150525]
[7]
Ghosh A, Joseph B, Anil S. Nitric Oxide in the Management of Respiratory Consequences in COVID-19: A Scoping Review of a Different Treatment Approach. Cureus. 2022 Apr:14(4):e23852. doi: 10.7759/cureus.23852. Epub 2022 Apr 5
[PubMed PMID: 35530860]
Level 2 (mid-level) evidence
[8]
Gebistorf F, Karam O, Wetterslev J, Afshari A. Inhaled nitric oxide for acute respiratory distress syndrome (ARDS) in children and adults. The Cochrane database of systematic reviews. 2016 Jun 27:2016(6):CD002787. doi: 10.1002/14651858.CD002787.pub3. Epub 2016 Jun 27
[PubMed PMID: 27347773]
Level 1 (high-level) evidence
[9]
Joshi MS, Ferguson TB Jr, Han TH, Hyduke DR, Liao JC, Rassaf T, Bryan N, Feelisch M, Lancaster JR Jr. Nitric oxide is consumed, rather than conserved, by reaction with oxyhemoglobin under physiological conditions. Proceedings of the National Academy of Sciences of the United States of America. 2002 Aug 6:99(16):10341-6
[PubMed PMID: 12124398]
[10]
Radomski MW, Moncada S. Regulation of vascular homeostasis by nitric oxide. Thrombosis and haemostasis. 1993 Jul 1:70(1):36-41
[PubMed PMID: 7694388]
[11]
Samama CM, Diaby M, Fellahi JL, Mdhafar A, Eyraud D, Arock M, Guillosson JJ, Coriat P, Rouby JJ. Inhibition of platelet aggregation by inhaled nitric oxide in patients with acute respiratory distress syndrome. Anesthesiology. 1995 Jul:83(1):56-65
[PubMed PMID: 7605019]
[13]
Hess D, Bigatello L, Hurford WE. Toxicity and complications of inhaled nitric oxide. Respiratory care clinics of North America. 1997 Dec:3(4):487-503
[PubMed PMID: 9443360]
[14]
Kinsella JP. Inhaled nitric oxide in the term newborn. Early human development. 2008 Nov:84(11):709-16. doi: 10.1016/j.earlhumdev.2008.08.002. Epub 2008 Oct 19
[PubMed PMID: 18930613]
[15]
Barrington KJ, Finer N, Pennaforte T, Altit G. Nitric oxide for respiratory failure in infants born at or near term. The Cochrane database of systematic reviews. 2017 Jan 5:1(1):CD000399. doi: 10.1002/14651858.CD000399.pub3. Epub 2017 Jan 5
[PubMed PMID: 28056166]
Level 1 (high-level) evidence
[16]
Zullino S, Buzzella F, Simoncini T. Nitric oxide and the biology of pregnancy. Vascular pharmacology. 2018 Nov:110():71-74. doi: 10.1016/j.vph.2018.07.004. Epub 2018 Aug 1
[PubMed PMID: 30076925]
[17]
Canobbio MM, Warnes CA, Aboulhosn J, Connolly HM, Khanna A, Koos BJ, Mital S, Rose C, Silversides C, Stout K, American Heart Association Council on Cardiovascular and Stroke Nursing; Council on Clinical Cardiology; Council on Cardiovascular Disease in the Young; Council on Functional Genomics and Translational Biology; and Council on Quality of Care and Outcomes Research. Management of Pregnancy in Patients With Complex Congenital Heart Disease: A Scientific Statement for Healthcare Professionals From the American Heart Association. Circulation. 2017 Feb 21:135(8):e50-e87. doi: 10.1161/CIR.0000000000000458. Epub 2017 Jan 12
[PubMed PMID: 28082385]
Level 2 (mid-level) evidence
[19]
Petit PC, Fine DH, Vásquez GB, Gamero L, Slaughter MS, Dasse KA. The Pathophysiology of Nitrogen Dioxide During Inhaled Nitric Oxide Therapy. ASAIO journal (American Society for Artificial Internal Organs : 1992). 2017 Jan/Feb:63(1):7-13. doi: 10.1097/MAT.0000000000000425. Epub
[PubMed PMID: 27556146]
[20]
Hallman M, Bry K, Turbow R, Waffarn F, Lappalainen U. Pulmonary toxicity associated with nitric oxide in term infants with severe respiratory failure. The Journal of pediatrics. 1998 May:132(5):827-9
[PubMed PMID: 9602194]
[21]
Clark RH, Kueser TJ, Walker MW, Southgate WM, Huckaby JL, Perez JA, Roy BJ, Keszler M, Kinsella JP. Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn. Clinical Inhaled Nitric Oxide Research Group. The New England journal of medicine. 2000 Feb 17:342(7):469-74
[PubMed PMID: 10675427]
[22]
Sinisterra S, Miravet E, Alfonso I, Soliz A, Papazian O. Methemoglobinemia in an infant receiving nitric oxide after the use of eutectic mixture of local anesthetic. The Journal of pediatrics. 2002 Aug:141(2):285-6
[PubMed PMID: 12183731]
[23]
Taylor MB, Christian KG, Patel N, Churchwell KB. Methemoglobinemia: Toxicity of inhaled nitric oxide therapy. Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies. 2001 Jan:2(1):99-101
[PubMed PMID: 12797897]
[24]
Peliowski A, Canadian Paediatric Society, Fetus and Newborn Committee. Inhaled nitric oxide use in newborns. Paediatrics & child health. 2012 Feb:17(2):95-100
[PubMed PMID: 23372402]
[25]
Liu K, Wang H, Yu SJ, Tu GW, Luo Z. Inhaled pulmonary vasodilators: a narrative review. Annals of translational medicine. 2021 Apr:9(7):597. doi: 10.21037/atm-20-4895. Epub
[PubMed PMID: 33987295]
Level 3 (low-level) evidence
[26]
Schreiber MD, Gin-Mestan K, Marks JD, Huo D, Lee G, Srisuparp P. Inhaled nitric oxide in premature infants with the respiratory distress syndrome. The New England journal of medicine. 2003 Nov 27:349(22):2099-107
[PubMed PMID: 14645637]
[27]
Neonatal Inhaled Nitric Oxide Study Group. Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure. The New England journal of medicine. 1997 Feb 27:336(9):597-604
[PubMed PMID: 9036320]
[28]
Sharma V, Berkelhamer S, Lakshminrusimha S. Persistent pulmonary hypertension of the newborn. Maternal health, neonatology and perinatology. 2015:1():14. doi: 10.1186/s40748-015-0015-4. Epub 2015 Jun 3
[PubMed PMID: 27057331]
[29]
Fuloria M, Aschner JL. Persistent pulmonary hypertension of the newborn. Seminars in fetal & neonatal medicine. 2017 Aug:22(4):220-226. doi: 10.1016/j.siny.2017.03.004. Epub 2017 Mar 23
[PubMed PMID: 28342684]
[30]
Dawson VL, Dawson TM. Nitric oxide neurotoxicity. Journal of chemical neuroanatomy. 1996 Jun:10(3-4):179-90
[PubMed PMID: 8811421]
[31]
Alano MA, Ngougmna E, Ostrea EM Jr, Konduri GG. Analysis of nonsteroidal antiinflammatory drugs in meconium and its relation to persistent pulmonary hypertension of the newborn. Pediatrics. 2001 Mar:107(3):519-23
[PubMed PMID: 11230592]